Cite
MLA Citation
Luis Paz-Ares et al.. “Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.” Lancet, vol. 394, no. 10212, 2019, pp. 1929–1939. http://access.bl.uk/ark:/81055/vdc_100137313470.0x000049